Back to results list
Please use this identifier to cite or link to this item:
|Title:||Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time||Authors:||Wang, M
Chemotherapy-induced peripheral neuropathy
|Issue Date:||2019||Publisher:||BioMed Central||Source:||BMC cancer, 27 Nov. 2019, v. 19, 1151, p. 1-10 How to cite?||Journal:||BMC cancer||Abstract:||Background Chemotherapy-induced peripheral neuropathy (CIPN) is common among cancer patients treated with neurotoxic chemotherapy agents. Better knowledge on symptom clusters of CIPN may help improve symptom management in clinical practice. This study aimed to identify symptom clusters of CIPN and to map their trajectories before initiation of chemotherapy to 12-month follow-up.
Methods A secondary analysis of a longitudinal dataset was conducted using principal component approach. The European Organization for the Research and Treatment of Cancer Quality of Life Questionnaires Core 30 and CIPN 20 were used to measure symptom clusters of CIPN in patients with mixed cancer diagnosis across 10 time points over 12 months.
Results Sample size in each assessment point ranged from 118 to 343 participants. Four CIPN symptom clusters were identified, including a clear sensory neuropathy symptom cluster, a mixed motor-sensory neuropathy symptom cluster, a mixed sensorimotor neuropathy symptom cluster, and a less clear autonomic neuropathy symptom cluster. The core symptoms in each symptom cluster were mostly stable while the secondary symptoms changed over time.
Conclusions The analysis suggests that CIPN is predominantly a sensory neuropathy with no evidence of a pure motor dysfunction but with mixed motor-related and autonomic changes accompanying sensory dysfunctions over time. Future symptom management strategies can be designed based on the morphology of CIPN.
|URI:||http://hdl.handle.net/10397/81775||ISSN:||1471-2407||DOI:||10.1186/s12885-019-6352-3||Rights:||© The Author(s). 2019Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, andreproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link tothe Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The following publication Wang, M., Cheng, H.L., Lopez, V. et al. Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time. BMC Cancer 19, 1151 (2019), 1-10 is available at https://dx.doi.org/10.1186/s12885-019-6352-3
|Appears in Collections:||Journal/Magazine Article|
Show full item record
Files in This Item:
|Wang_Redefining_Chemotherapy-induced_Peripheral.pdf||564.95 kB||Adobe PDF||View/Open|
Citations as of May 6, 2020
Citations as of May 6, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.